NCT00045279 PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00042965 Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00039429 Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00039052 Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer Status COMPLETED Phase PHASE1
NCT00036959 ABT-751 in Treating Young Patients With Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00036712 Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation Status UNKNOWN Phase PHASE2
NCT00033137 Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer Status RECRUITING Phase N/A
NCT00031564 Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 Status COMPLETED Phase PHASE2
NCT00030888 UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer Status UNKNOWN Phase PHASE2
NCT00030342 Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00030108 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy Status COMPLETED Phase PHASE1
NCT00027664 Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer Status UNKNOWN Phase PHASE2
NCT00027573 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer Status COMPLETED Phase PHASE2
NCT00026884 Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease Status RECRUITING Phase N/A
NCT00025519 Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer Status WITHDRAWN Phase PHASE2
NCT00025103 Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney Status UNKNOWN Phase PHASE2
NCT00024388 Chemotherapy in Treating Patients With Metastatic Kidney Cancer Status UNKNOWN Phase PHASE2
NCT00024258 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors Status COMPLETED Phase PHASE2